Your browser doesn't support javascript.
loading
Salvia miltiorrhiza Bunge (Danshen) based nano-delivery systems for anticancer therapeutics.
Jia, Yiyang; Yao, Dandan; Bi, Hui; Duan, Jing; Liang, Wei; Jing, Ziwei; Liu, Mei.
Affiliation
  • Jia Y; Department of Pharmacy, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China.
  • Yao D; Department of Pharmacy, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China.
  • Bi H; Department of Pharmacy, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China.
  • Duan J; Department of Pharmacy, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China.
  • Liang W; Department of Traditional Chinese Medicine, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China.
  • Jing Z; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Electronic address: fccjingzw@zzu.edu.cn.
  • Liu M; Department of Pharmacy, The Air Force Hospital of Eastern Theater Command, Nanjing, 210002, China. Electronic address: 16651690576@163.com.
Phytomedicine ; 128: 155521, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38489891
ABSTRACT

BACKGROUND:

The ancient Chinese herb Salvia miltiorrhiza Bunge (Danshen), plays the important role in cardiovascular and cerebrovascular disease. Furthermore, Danshen could also be used for curing carcinogenesis. Up to now, the anti-tumor effects of the main active constituents of Danshen have made great progress. However, the bioavailability of the active constituents of Danshen were restricted by their unique physical characteristics, like low oral bioavailability, rapid degradation in vivo and so on.

PURPOSE:

With the leap development of nano-delivery systems, the shortcomings of the active constituents of Danshen have been greatly ameliorated. This review tried to summarize the recent progress of the active constituents of Danshen based delivery systems used for anti-tumor therapeutics.

METHODS:

A systematic literature search was conducted using 5 databases (Embase, Google scholar, PubMed, Scopus and Web of Science databases) for the identification of relevant data published before September 2023. The words "Danshen", "Salvia miltiorrhiza", "Tanshinone", "Salvianolic acid", "Rosmarinic acid", "tumor", "delivery", "nanomedicine" and other active ingredients contained in Danshen were searched in the above databases to gather information about pharmaceutical decoration for the active constituents of Danshen used for anti-tumor therapeutics.

RESULTS:

The main extracts of Danshen could inhibit the proliferation of tumor cells effectively and a great deal of studies were conducted to design drug delivery systems to ameliorate the anti-tumor effect of the active contents of Danshen through different ways, like improving bioavailability, increasing tumor targeting ability, enhancing biological barrier permeability and co-delivering with other active agents.

CONCLUSION:

This review systematically represented recent progress of pharmaceutical decorations for the active constituents of Danshen used for anti-tumor therapeutics, revealing the diversity of nano-decoration skills and trying to inspire more designs of Danshen based nanodelivery systems, with the hope that bringing the nanomedicine of the active constituents of Danshen for anti-tumor therapeutics from bench to bedside in the near future.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Salvia miltiorrhiza / Antineoplastic Agents, Phytogenic Limits: Animals / Humans Language: En Journal: Phytomedicine Journal subject: TERAPIAS COMPLEMENTARES Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Salvia miltiorrhiza / Antineoplastic Agents, Phytogenic Limits: Animals / Humans Language: En Journal: Phytomedicine Journal subject: TERAPIAS COMPLEMENTARES Year: 2024 Document type: Article Affiliation country: Country of publication: